APT Medical Inc.

Shanghai Stock Exchange 688617.SS

APT Medical Inc. Price to Sales Ratio (P/S) on January 14, 2025: 20.11

APT Medical Inc. Price to Sales Ratio (P/S) is 20.11 on January 14, 2025, a 36.89% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

APT Medical Inc. 52-week high Price to Sales Ratio (P/S) is 25.95 on October 08, 2024, which is 29.06% above the current Price to Sales Ratio (P/S).
APT Medical Inc. 52-week low Price to Sales Ratio (P/S) is 12.46 on July 30, 2024, which is -38.05% below the current Price to Sales Ratio (P/S).
APT Medical Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 18.74.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 688617.SS

APT Medical Inc.

CEO	Mr. Zhenghui Cheng
IPO Date	Jan. 7, 2021
Location	China
Headquarters	601, Building B
Employees	2,155
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.

Key trends

Past 5 years